| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
2 companies
Brainard Diana is a Chief Executive Officer at Kalaris Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $5.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 8,706 | $0.55 | $4,775.24 | -1.2% | -25.6% | -48.1% | |
| Nov 5, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 10,609 | $0.86 | $9,175.72 | -1.4% | -57.0% | -78.0% | |
| Oct 21, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 9,752 | $0.78 | $7,596.81 | -1.3% | -47.4% | -73.5% | |
| Oct 3, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 1,493 | $0.81 | $1,216.50 | -0.2% | -45.0% | -64.7% | |
| Aug 20, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 5,390 | $0.74 | $3,995.61 | -0.7% | -23.3% | -85.2% | |
| Aug 19, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 3,091 | $0.76 | $2,347.61 | -0.4% | -24.6% | -85.4% | |
| Aug 5, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 10,847 | $0.73 | $7,970.38 | -1.4% | +21.3% | -84.8% | |
| Jul 19, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 9,731 | $0.75 | $7,299.22 | -1.2% | +3.8% | -86.0% | |
| Jul 2, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 1,489 | $0.72 | $1,072.08 | -0.2% | +10.0% | -84.9% | |
| May 21, 2024 | KLRS Kalaris Therapeutics, Inc. | Chief Executive Officer | Sell | 5,149 | $0.79 | $4,079.55 | -0.7% | -3.5% | -83.7% |